Literature DB >> 12839071

Demographic and clinical characteristics of geriatric horses: 467 cases (1989-1999).

Margaret M Brosnahan1, Mary Rose Paradis.   

Abstract

OBJECTIVE: To describe the demographic and clinical characteristics of a population of geriatric horses.
DESIGN: Retrospective study. ANIMALS: 467 horses that were > or = 20 years of age. PROCEDURE: Medical records of 539 geriatric horses that were evaluated at a university large animal hospital between 1989 and 1999 were reviewed. Data collected included signalment, reason for evaluation, specific diagnoses, surgical procedures, inpatient or outpatient care, duration of hospitalization, and outcome.
RESULTS: 467 horses met the criteria for inclusion in the study. Horses that were > or = 20 years of age comprised 2.2 and 12.5% of horses evaluated during 1989 and 1999, respectively. Pony breeds were significantly overrepresented in the > or = 30-years-of-age group. Gastrointestinal tract, musculoskeletal, and respiratory tract problems were most frequently reported. Colic was the most common clinical sign, followed by lameness. Diagnoses made most frequently included pituitary dysfunction, strangulating lipoma of the small intestine, laminitis, heaves, large colon impaction, and gastric ulcers. Pituitary dysfunction was significantly more prevalent in horses that were > 30 years of age. Laminitis was significantly associated with the presence of pituitary dysfunction. CONCLUSIONS AND CLINICAL RELEVANCE: It was difficult to assess association of age with illnesses identified in these horses. Demographic data and information regarding common diseases of horses that are > or = 20 years of age are limited but will become increasingly important as this geriatric population increases.

Entities:  

Mesh:

Year:  2003        PMID: 12839071     DOI: 10.2460/javma.2003.223.93

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  36 in total

Review 1.  The response of bone, articular cartilage and tendon to exercise in the horse.

Authors:  Elwyn C Firth
Journal:  J Anat       Date:  2006-04       Impact factor: 2.610

Review 2.  Genes against aging.

Authors:  Richard A Miller
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-28       Impact factor: 6.053

Review 3.  "Dividends" from research on aging--can biogerontologists, at long last, find something useful to do?

Authors:  Richard A Miller
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-02-18       Impact factor: 6.053

4.  Equine pituitary pars intermedia dysfunction: An international survey of veterinarians' approach to diagnosis, management, and estimated prevalence.

Authors:  James L Carmalt; Cheryl L Waldner; Andrew L Allen
Journal:  Can J Vet Res       Date:  2017-10       Impact factor: 1.310

5.  Body size, inbreeding, and lifespan in domestic dogs.

Authors:  Jennifer Yordy; Cornelia Kraus; Jessica J Hayward; Michelle E White; Laura M Shannon; Kate E Creevy; Daniel E L Promislow; Adam R Boyko
Journal:  Conserv Genet       Date:  2019-12-05       Impact factor: 2.538

Review 6.  Growth Hormone Deficiency: Health and Longevity.

Authors:  Manuel H Aguiar-Oliveira; Andrzej Bartke
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

Review 7.  Healthspan and longevity can be extended by suppression of growth hormone signaling.

Authors:  Andrzej Bartke
Journal:  Mamm Genome       Date:  2016-02-24       Impact factor: 2.957

Review 8.  The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer.

Authors:  Vladimir N Anisimov; Andrzej Bartke
Journal:  Crit Rev Oncol Hematol       Date:  2013-02-21       Impact factor: 6.312

Review 9.  Somatotropic signaling: trade-offs between growth, reproductive development, and longevity.

Authors:  Andrzej Bartke; Liou Y Sun; Valter Longo
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

Review 10.  Growth hormone and aging: a challenging controversy.

Authors:  Andrzej Bartke
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.